{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T23:09:15Z","timestamp":1769728155316,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,5,25]],"date-time":"2011-05-25T00:00:00Z","timestamp":1306281600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s12185-011-0867-y","type":"journal-article","created":{"date-parts":[[2011,5,24]],"date-time":"2011-05-24T02:25:31Z","timestamp":1306203931000},"page":"704-714","source":"Crossref","is-referenced-by-count":42,"title":["Chronic treatment of paroxysmal nocturnal hemoglobinuria patients with eculizumab: safety, efficacy, and unexpected laboratory phenomena"],"prefix":"10.1007","volume":"93","author":[{"given":"Alexander","family":"R\u00f6th","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Hock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Konik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Christoph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"D\u00fchrsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,25]]},"reference":[{"key":"867_CR1","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1182\/blood-2005-04-1717","volume":"106","author":"C Parker","year":"2005","unstructured":"Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R, et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood. 2005;106:3699\u2013709.","journal-title":"Blood"},{"key":"867_CR2","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJM199511093331904","volume":"333","author":"P Hillmen","year":"1995","unstructured":"Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1995;333:1253\u20138.","journal-title":"N Engl J Med"},{"key":"867_CR3","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1182\/blood-2008-01-133918","volume":"112","author":"RP Latour de","year":"2008","unstructured":"de Latour RP, Mary JY, Salanoubat C, Terriou L, Etienne G, Mohty M, et al. Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood. 2008;112:3099\u2013106.","journal-title":"Blood"},{"key":"867_CR4","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/stem.140396","volume":"14","author":"CJ Parker","year":"1996","unstructured":"Parker CJ. Molecular basis of paroxysmal nocturnal hemoglobinuria. Stem Cells. 1996;14:396\u2013411.","journal-title":"Stem Cells"},{"key":"867_CR5","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1056\/NEJM199010253231707","volume":"323","author":"M Yamashina","year":"1990","unstructured":"Yamashina M, Ueda E, Kinoshita T, Takami T, Ojima A, Ono H, et al. Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1990;323:1184\u20139.","journal-title":"N Engl J Med"},{"key":"867_CR6","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1002\/eji.1830221029","volume":"22","author":"N Motoyama","year":"1992","unstructured":"Motoyama N, Okada N, Yamashina M, Okada H. Paroxysmal nocturnal hemoglobinuria due to hereditary nucleotide deletion in the HRF20 (CD59) gene. Eur J Immunol. 1992;22:2669\u201373.","journal-title":"Eur J Immunol"},{"key":"867_CR7","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/0092-8674(93)90250-T","volume":"73","author":"J Takeda","year":"1993","unstructured":"Takeda J, Miyata T, Kawagoe K, Iida Y, Endo Y, Fujita T, et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell. 1993;73:703\u201311.","journal-title":"Cell"},{"key":"867_CR8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/j.1460-2075.1994.tb06240.x","volume":"13","author":"M Bessler","year":"1994","unstructured":"Bessler M, Mason PJ, Hillmen P, Miyata T, Yamada N, Takeda J, et al. Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J. 1994;13:110\u20137.","journal-title":"EMBO J"},{"key":"867_CR9","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","volume":"293","author":"RP Rother","year":"2005","unstructured":"Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005;293:1653\u201362.","journal-title":"JAMA"},{"key":"867_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/BF02983209","volume":"77","author":"WF Rosse","year":"2003","unstructured":"Rosse WF, Nishimura J. Clinical manifestations of paroxysmal nocturnal hemoglobinuria: present state and future problems. Int J Hematol. 2003;77:113\u201320.","journal-title":"Int J Hematol"},{"key":"867_CR11","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0161-5890(96)00078-8","volume":"33","author":"TC Thomas","year":"1996","unstructured":"Thomas TC, Rollins SA, Rother RP, Giannoni MA, Hartman SL, Elliott EA, et al. Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv. Mol Immunol. 1996;33:1389\u2013401.","journal-title":"Mol Immunol"},{"key":"867_CR12","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMoa061648","volume":"355","author":"P Hillmen","year":"2006","unstructured":"Hillmen P, Young NS, Schubert J, Brodsky RA, Socie G, Muus P, et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med. 2006;355:1233\u201343.","journal-title":"N Engl J Med"},{"key":"867_CR13","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1182\/blood-2007-06-094136","volume":"111","author":"RA Brodsky","year":"2008","unstructured":"Brodsky RA, Young NS, Antonioli E, Risitano AM, Schrezenmeier H, Schubert J, et al. Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood. 2008;111:1840\u20137.","journal-title":"Blood"},{"key":"867_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1365-2141.2008.07183.x","volume":"142","author":"J Schubert","year":"2008","unstructured":"Schubert J, Hillmen P, R\u00f6th A, Young NS, Elebute MO, Szer J, et al. Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol. 2008;142:263\u201372.","journal-title":"Br J Haematol"},{"key":"867_CR15","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1182\/blood-2008-11-189944","volume":"113","author":"AM Risitano","year":"2009","unstructured":"Risitano AM, Notaro R, Marando L, Serio B, Ranaldi D, Seneca E, et al. Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab. Blood. 2009;113:4094\u2013100.","journal-title":"Blood"},{"key":"867_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1046\/j.1365-2257.2001.00357.x","volume":"23","author":"U Oelschlaegel","year":"2001","unstructured":"Oelschlaegel U, Besson I, Arnoulet C, Sainty D, Nowak R, Naumann R, et al. A standardized flow cytometric method for screening paroxysmal nocturnal haemoglobinuria (PNH) measuring CD55 and CD59 expression on erythrocytes and granulocytes. Clin Lab Haematol. 2001;23:81\u201390.","journal-title":"Clin Lab Haematol"},{"key":"867_CR17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/cyto.b.20151","volume":"72","author":"DR Sutherland","year":"2007","unstructured":"Sutherland DR, Kuek N, Davidson J, Barth D, Chang H, Yeo E, et al. Diagnosing PNH with FLAER and multiparameter flow cytometry. Cytom B Clin Cytom. 2007;72:167\u201377.","journal-title":"Cytom B Clin Cytom"},{"key":"867_CR18","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1182\/blood-2008-04-151613","volume":"112","author":"AM Risitano","year":"2008","unstructured":"Risitano AM, Marando L, Seneca E, Rotoli B. Hemoglobin normalization after splenectomy in a paroxysmal nocturnal hemoglobinuria patient treated by eculizumab. Blood. 2008;112:449\u201351.","journal-title":"Blood"},{"key":"867_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s12185-010-0493-0","volume":"91","author":"A R\u00f6th","year":"2010","unstructured":"R\u00f6th A, Peine S, D\u00fchrsen U. Paroxysmal nocturnal hemoglobinuria turning Coombs-positive. Int J Hematol. 2010;91:159\u201360.","journal-title":"Int J Hematol"},{"key":"867_CR20","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3324\/haematol.2009.007229","volume":"95","author":"A Hill","year":"2010","unstructured":"Hill A, Rother RP, Arnold L, Kelly R, Cullen MJ, Richards SJ, et al. Eculizumab prevents intravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria and unmasks low-level extravascular hemolysis occurring through C3 opsonization. Haematologica. 2010;95:567\u201373.","journal-title":"Haematologica"},{"key":"867_CR21","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1055\/s-0028-1124013","volume":"134","author":"A R\u00f6th","year":"2009","unstructured":"R\u00f6th A, D\u00fchrsen U, Schrezenmeier H, Schubert J. Paroxysmal nocturnal hemoglobinuria (PNH). Dtsch Med Wochenschr. 2009;134:404\u20139.","journal-title":"Dtsch Med Wochenschr"},{"key":"867_CR22","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1182\/blood-2007-06-095646","volume":"110","author":"P Hillmen","year":"2007","unstructured":"Hillmen P, Muus P, D\u00fchrsen U, Risitano AM, Schubert J, Luzzatto L, et al. Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood. 2007;110:4123\u20138.","journal-title":"Blood"},{"key":"867_CR23","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1749-6632.2009.04633.x","volume":"1173","author":"HD Pettigrew","year":"2009","unstructured":"Pettigrew HD, Teuber SS, Gershwin ME. Clinical significance of complement deficiencies. Ann N Y Acad Sci. 2009;1173:108\u201323.","journal-title":"Ann N Y Acad Sci"},{"key":"867_CR24","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(06)67932-4","volume":"367","author":"MJ Thompson","year":"2006","unstructured":"Thompson MJ, Ninis N, Perera R, Mayon-White R, Phillips C, Bailey L, et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet. 2006;367:397\u2013403.","journal-title":"Lancet"},{"key":"867_CR25","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/ajh.21757","volume":"85","author":"P Hillmen","year":"2010","unstructured":"Hillmen P, Elebute M, Kelly R, Urbano-Ispizua A, Hill A, Rother RP, et al. Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria. Am J Hematol. 2010;85:553\u20139.","journal-title":"Am J Hematol"},{"key":"867_CR26","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1365-2141.2010.08096.x","volume":"149","author":"A Hill","year":"2010","unstructured":"Hill A, Rother RP, Wang X, Morris SM Jr, Quinn-Senger K, Kelly R, et al. Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol. 2010;149:414\u201325.","journal-title":"Br J Haematol"},{"key":"867_CR27","first-page":"639","volume":"116","author":"RJ Kelly","year":"2010","unstructured":"Kelly RJ, Hill A, Mitchell LD, Richards SJ, Arnold LM, Valters GL, et al. Long term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria (PNH): sustained efficacy and improved survival. ASH Annu Meet Abstr. 2010;116:639.","journal-title":"ASH Annu Meet Abstr"},{"key":"867_CR28","first-page":"3","volume":"5","author":"JV Dacie","year":"1972","unstructured":"Dacie JV, Lewis SM. Paroxysmal nocturnal haemoglobinuria: clinical manifestations, haematology, and nature of the disease. Ser Haematol. 1972;5:3\u201323.","journal-title":"Ser Haematol"},{"key":"867_CR29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1182\/blood.V60.1.20.20","volume":"60","author":"WF Rosse","year":"1982","unstructured":"Rosse WF. Treatment of paroxysmal nocturnal hemoglobinuria. Blood. 1982;60:20\u20133.","journal-title":"Blood"},{"key":"867_CR30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/00005792-196609000-00001","volume":"45","author":"RC Hartmann","year":"1966","unstructured":"Hartmann RC, Jenkins DE Jr, McKee LC, Heyssel RM. Paroxysmal nocturnal hemoglobinuria: clinical and laboratory studies relating to iron metabolism and therapy with androgen and iron. Medicine (Baltimore). 1966;45:331\u201363.","journal-title":"Medicine (Baltimore)"},{"key":"867_CR31","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1182\/blood-2009-01-196329","volume":"113","author":"A R\u00f6th","year":"2009","unstructured":"R\u00f6th A, H\u00fcttmann A, Rother RP, D\u00fchrsen U, Philipp T. Long-term efficacy of the complement inhibitor eculizumab in cold agglutinin disease. Blood. 2009;113:3885\u20136.","journal-title":"Blood"},{"key":"867_CR32","first-page":"1992","volume":"114","author":"R Kelly","year":"2009","unstructured":"Kelly R, Richards S, Arnold L, Valters G, Cullen M, Hill A, et al. A spontaneous reduction of clone size in paroxysmal nocturnal hemoglobinuria patients treated with eculizumab for greater than 12 months. ASH Annu Meet Abstr. 2009;114:1992.","journal-title":"ASH Annu Meet Abstr"},{"key":"867_CR33","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1056\/NEJMc0808527","volume":"360","author":"J N\u00fcrnberger","year":"2009","unstructured":"N\u00fcrnberger J, Philipp T, Witzke O, Opazo SA, Vester U, Baba HA, et al. Eculizumab for atypical hemolytic-uremic syndrome. N Engl J Med. 2009;360:542\u20134.","journal-title":"N Engl J Med"},{"key":"867_CR34","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1056\/NEJMc0809959","volume":"360","author":"RA Gruppo","year":"2009","unstructured":"Gruppo RA, Rother RP. Eculizumab for congenital atypical hemolytic-uremic syndrome. N Engl J Med. 2009;360:544\u20136.","journal-title":"N Engl J Med"},{"key":"867_CR35","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1600-6143.2008.02451.x","volume":"9","author":"JE Locke","year":"2009","unstructured":"Locke JE, Magro CM, Singer AL, Segev DL, Haas M, Hillel AT, et al. The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection. Am J Transplant. 2009;9:231\u20135.","journal-title":"Am J Transplant"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-011-0867-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-011-0867-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-011-0867-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-011-0867-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T13:03:20Z","timestamp":1592571800000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-011-0867-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,25]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["867"],"URL":"https:\/\/doi.org\/10.1007\/s12185-011-0867-y","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,25]]}}}